Nifedipine aggravates cyclosporine A-induced gingival hyperplasia.

Abstract

Gingival hyperplasia is a common side-effect of immunosuppression with cyclosporine A. Nifedipine is often used to control hypertension in kidney graft recipients. Analysis of gingival status in 106 children transplanted at our centre, and treated either with azathioprine, cyclosporine A or both, revealed significantly higher degrees of gingival overgrowth in those children receiving a combination of cyclosporine A and nifedipine compared with those children treated with cyclosporine A or nifedipine alone. Seven children undergoing gingivectomy at our centre over the past few years had received this combination. After a change in the antihypertensive regimen, avoiding long-term nifedipine medication, and improved dental care with chlorhexidine gel, we noted a reduction in the degree of gingival hyperplasia. In the majority of patients, nifedipine could be replaced by a single drug, usually hydralazine. We therefore recommend avoiding calcium channel blockers in the long-term management of hypertension in patients receiving cyclosporine.

• Authors: A Bökenkamp, B Bohnhorst, C Beier, N Albers, G Offner, J Brodehl
• Journal: Pediatric nephrology (Berlin, Germany) (Pediatr Nephrol) Vol. 8 Issue 2 Pg. 181-5 (Apr 1994) ISSN: 0931-041X [Print] Germany
• PMID: 8018496 (Publication Type: Journal Article)

Chemical References

• Hydralazine
• Cyclosporine
• Nifedipine
• Azathioprine

Topics

• Adolescent
• Adult
• Azathioprine (therapeutic use)
• Cyclosporine (adverse effects, therapeutic use)
• Drug Therapy, Combination
• Female
• Gingival Hyperplasia (chemically induced)
• Graft Rejection (drug therapy)
• Humans
• Hydralazine (therapeutic use)
• Hypertension (drug therapy)
• Kidney Transplantation
• Male
• Nifedipine (adverse effects, therapeutic use)